Skip to content

KALOS-03 Bipolar

by Biotronik Sales, Inc. 510(k)

Active United States

510(k) K822907

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK822907 Date1 Nov 1982ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DXY
Device Class
Class III
Regulation
21 CFR Part 870.3610
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Kalos-03 Bipolar is an implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It falls under the classification of a Class III medical device, recognized for its high-risk, life-sustaining function in cardiovascular applications.

This device is intended for single-use implantation and is regulated under FDA 510(k) clearance (K822907) as a substantially equivalent device to a predicate. Supplied sterile, it is intended for use in controlled clinical settings by trained medical professionals. The device adheres to regulatory standards outlined under 870.3610 and is categorized under product code DXY.

Other devices from Biotronik Sales, Inc.

See all devices from Biotronik Sales, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the KALOS-03 Bipolar pacemaker, and how does it function in the body?

    The KALOS-03 Bipolar is designed as an implantable pacemaker pulse-generator to regulate cardiac rhythm by delivering controlled electrical impulses to the heart. It is intended for patients with abnormal heartbeats, ensuring proper pacing to maintain a steady heartbeat when the heart’s natural conduction system is compromised.

  • Is the KALOS-03 Bipolar intended for reuse, or is it meant to be implanted once and discarded?

    The device is explicitly intended for single-use implantation, meaning it is not designed for removal and reuse. After implantation, it remains in the patient’s body as a permanent solution for cardiac rhythm regulation.

  • How is the KALOS-03 Bipolar supplied, and what precautions should be taken during handling?

    The device is supplied sterile and must be handled in a controlled clinical setting by trained medical professionals. Since it is implanted directly into the body, sterile techniques are critical to prevent infection or contamination during the procedure.

  • What regulatory pathway does the KALOS-03 Bipolar follow, and how does it compare to other pacemakers?

    The KALOS-03 Bipolar is regulated under the FDA 510(k) clearance process (K822907) as a Class III device, classified as substantially equivalent to a predicate. This pathway confirms its safety and effectiveness for life-sustaining cardiovascular applications, aligning with standards under 21 CFR 870.3610 and categorized under product code DXY.

  • Are there multiple models or sizes available for the KALOS-03 Bipolar, or is it a single standardized unit?

    The provided data does not specify multiple models or sizes for the KALOS-03 Bipolar, implying it is likely a single standardized unit designed for general use in pacemaker implantation. For precise sizing or model variations, consult the manufacturer’s technical documentation or a representative.